1. Home
  2. PCRX vs ENOV Comparison

PCRX vs ENOV Comparison

Compare PCRX & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo Enovis Corporation

ENOV

Enovis Corporation

SELL

Current Price

$27.91

Market Cap

1.4B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
PCRX
ENOV
Founded
2006
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
PCRX
ENOV
Price
$36.48
$27.91
Analyst Decision
Hold
Strong Buy
Analyst Count
9
13
Target Price
$33.57
★ $37.83
AVG Volume (30 Days)
958.5K
★ 1.7M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.44
N/A
EPS
★ 0.89
N/A
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.84
$3.93
Revenue Next Year
$4.73
$4.76
P/E Ratio
$40.96
★ N/A
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$16.70
52 Week High
$36.67
$31.67

Technical Indicators

Market Signals
Indicator
PCRX
ENOV
Relative Strength Index (RSI) 82.40 66.41
Support Level $22.00 $20.87
Resistance Level $36.67 $30.78
Average True Range (ATR) 0.04 1.52
MACD -0.37 0.41
Stochastic Oscillator 90.00 78.73

Price Performance

Historical Comparison
PCRX
ENOV

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: